SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1386multiplesclerosis.com While the item seemed new I just found an older report abaknahow-2/17/2002
1385Hope this helps. multiplesclerosis.com BTW try using this search engine. wiseaknahow-2/17/2002
1384George, is there more publicly available information about this trial? Would beHarold Engstrom-2/17/2002
1383Better than Avonex? pslgroup.com Snip Interferon-Beta-1b Appears More Effectiaknahow-2/17/2002
1382Thank you, excellent link !!!Cacaito-2/6/2002
1381Psoriasis Therapy in the New Millennium and aknahow-1/30/2002
1380Thursday December 13, 3:17 pm Eastern Time Press Release SOURCE: Serono, S.A. Setnsaf-12/16/2001
1379On November 1, BGEN indicated that Amevive would be a $500 million dollar drug taknahow-11/8/2001
1378George, his response was murky. However, BGEN is having an analysts day in NovemMark Bong-10/18/2001
1377Mark, you still in this one? Any thoughts on the meaning of the target dates foaknahow-10/17/2001
1376Data is for period ended on June 30. Pre CTD filing and pre disaster of Sept. 1aknahow-10/1/2001
1375Anyone know which Modules were filed? II. The Common Technical Document Thaknahow-9/30/2001
1374Mark, guess who wrote this? "But again, I return aknahow-9/28/2001
1373CAMBRIDGE, Mass., Sept. 6 /PRNewswire/-- A study by Biogen scientists published nigel bates-9/7/2001
1372Street.com article on Xanelim problems Biotech Investors Scratching Heads Over XMark Bong-8/24/2001
1371Biogen Research Reported in 'Science' Signals Important New Target for DMark Bong-8/16/2001
1370Gw, yes they did allow limited restricted topical treatments, is the compassionaCacaito-7/26/2001
1369Are you saying Amevive trials allowed use of topical steroids during the trial oaknahow-7/26/2001
1368""Patients were not allowed to receive systemic treatments, phototheraaknahow-7/26/2001
1367NEJM article about Amevive is out, great data, and very important: "PatienCacaito-7/25/2001
1366Nice partnership. Market seems to be ignoring it, or perhaps some may think thiaknahow-7/16/2001
1365BOTHELL, Wash. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--July 16, 2001--ICOS Corpnigel bates-7/16/2001
1364Interesting battle going on today. Strong buy message for 500,000 shares seems aknahow-7/11/2001
1363Some like I Watch and some don't. Still the BGEN chart showed regularl buy aknahow-7/11/2001
1362Time (ET) After Hours aknahow-7/10/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News